IRIS PubliCatt

Scaldaferri, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.441
EU - Europa 5.364
AS - Asia 1.265
SA - Sud America 44
AF - Africa 35
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 17
Totale 12.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.394
DE - Germania 1.332
SE - Svezia 1.238
IT - Italia 1.006
CN - Cina 742
FR - Francia 354
IE - Irlanda 329
UA - Ucraina 328
PL - Polonia 255
GB - Regno Unito 157
IN - India 127
FI - Finlandia 119
TR - Turchia 99
IR - Iran 77
KR - Corea 42
HK - Hong Kong 40
BE - Belgio 38
NL - Olanda 34
CA - Canada 33
JP - Giappone 31
ES - Italia 26
SG - Singapore 26
RU - Federazione Russa 24
BR - Brasile 23
CZ - Repubblica Ceca 22
CI - Costa d'Avorio 19
AU - Australia 16
EU - Europa 16
CH - Svizzera 14
VN - Vietnam 14
RO - Romania 13
BG - Bulgaria 12
IQ - Iraq 12
MX - Messico 11
CL - Cile 10
PH - Filippine 10
TW - Taiwan 10
AT - Austria 9
IL - Israele 7
PT - Portogallo 7
HU - Ungheria 6
LT - Lituania 6
PE - Perù 6
SI - Slovenia 6
NZ - Nuova Zelanda 5
ZA - Sudafrica 5
GR - Grecia 4
HR - Croazia 4
ID - Indonesia 4
TH - Thailandia 4
AR - Argentina 3
CY - Cipro 3
EG - Egitto 3
MK - Macedonia 3
NG - Nigeria 3
PK - Pakistan 3
AL - Albania 2
BD - Bangladesh 2
BZ - Belize 2
DK - Danimarca 2
EE - Estonia 2
KW - Kuwait 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
RS - Serbia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CO - Colombia 1
EC - Ecuador 1
GE - Georgia 1
GH - Ghana 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UG - Uganda 1
Totale 12.187
Salva come PNG Salva come JPEG
Città #
Chandler 1.397
Ashburn 487
Dublin 324
Jacksonville 239
Warsaw 226
San Mateo 202
New York 175
Ann Arbor 167
Wilmington 154
Rome 148
Beijing 144
Boston 141
Nanjing 139
Cattolica 125
Milan 119
Marseille 116
Princeton 115
Fairfield 102
Dearborn 90
Woodbridge 88
Redwood City 85
Houston 76
Seattle 72
Nürnberg 71
Izmir 68
Lawrence 62
Bremen 58
Hangzhou 53
Munich 52
Nanchang 45
Redmond 42
Shanghai 37
Hebei 36
Helsinki 35
Augusta 34
Pune 34
Mountain View 33
Lancaster 32
Cambridge 31
Chicago 29
Brussels 28
Tianjin 28
Los Angeles 27
Shenyang 27
Kunming 26
London 26
Norwalk 26
Changsha 25
Detroit 25
Seoul 25
Zhengzhou 25
Washington 24
Boardman 22
Kish 22
Trieste 22
Jiaxing 21
Kraków 21
Fremont 20
Abidjan 19
Guangzhou 18
Andover 17
Leawood 17
Monza 15
Paris 14
Central 13
Naples 13
San Diego 13
Singapore 13
Hefei 12
University Park 12
Busto Arsizio 11
Tehran 11
Hong Kong 10
Jinan 10
Tokyo 10
Berlin 9
Cagliari 9
Falls Church 9
Lanzhou 9
Zurich 9
Florence 8
Goyang-si 8
Monmouth Junction 8
São Paulo 8
Vienna 8
Ardabil 7
Atlanta 7
Baghdad 7
Bari 7
Brno 7
Frankfurt am Main 7
Lappeenranta 7
San Francisco 7
Sofia 7
Toronto 7
Ceska 6
Changchun 6
Edinburgh 6
Hanoi 6
Hooghalen 6
Totale 6.536
Salva come PNG Salva come JPEG
Nome #
The interpaly between immune system and microbiota in gynecological diseases : a narrative review. 390
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 291
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 185
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 181
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 156
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 150
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 147
Management of acute dyarrhea: current and future trends 138
The role of diet on gut microbiota composition 135
The gut barrier: new acquisitions and therapeutic approaches 134
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 130
13C-octanoic acid breath test to study gastric emptying time 125
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 124
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 124
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 124
Bacterial flora as a cause or treatment of chronic diarrhea 123
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 121
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 115
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease 111
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 111
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 109
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 108
Assessment of neurological manifestations in hospitalized patients with COVID-19 108
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 107
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 107
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 99
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 98
Dietary magnesium: the magic mineral that protects from colon cancer? 98
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 97
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? 93
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 93
Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome 90
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 89
The gastrointestinal microbiome - functional interference between stomach and intestine 89
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease 88
Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride 87
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 86
Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers 86
Origin of celiac disease: How old are predisposing haplotypes? 85
Use and indications of cholestyramine and bile acid sequestrants 85
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 85
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 85
Use and indications of cholestyramine and bile acid sequestrants 84
Differential CD133 expression pattern during mouse colon tumorigenesis 84
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 84
European consensus conference on faecal microbiota transplantation in clinical practice 84
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 84
-Extraintestinal manifestations in inflammatory Bowel disease. 83
A novel pathogenic role for microvasculature in inflammatory bowel disease. 83
Commensal Clostridia: leading players in the maintenance of gut homeostasis 83
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 83
RECURRENT PREGNANCY LOSS IS ASSSOCIATED TO LEAKY GUT: A NOVEL PATHOGENIC MODEL OF ENDOMETRIUM INFLAMMATION ? 83
A) Platelets: new players in the mucosal scenario of inflammatory bowel disease. 82
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 79
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients 79
Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials 77
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 77
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 76
Small bowel bacterial overgrowth and type 1 diabetes 74
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 74
Pancreatic function assessment 73
Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy) 71
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 71
Bacillus clausii and gut homeostasis: state of the art and future perspectives 70
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 67
Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease. A case-control study 67
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. 65
Gut microbiota and inflammatory bowel disease: an update 65
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 65
Anti-TNF-related leukocytoclastic vasculitis in ulcerative colitis: a case report 65
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 64
Endoscopic ultrasound-guided fine-needle tissue acquisition from a subepithelial lesion in the distal ileum using the forward-viewing echoendoscope 63
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 63
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 62
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 61
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 61
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 61
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 60
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 60
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 59
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? 59
The current practice of lynch syndrome diagnosis and management in Italy: A qualitative assessment 59
Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment. 58
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 58
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 58
Cancer and Mediterranean Diet: A Review 58
Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL) 56
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 56
Editorial--Is there still a place for breath tests in gastroenterology? 55
Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD) 55
Enterography CT without and with water enema in patients with Crohn's disease: Results from a comparative observational study in comparison with endoscopy 54
Acute refractory intestinal pseudo-obstruction in melas: Efficacy of prucalopride 54
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 54
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy 54
Can we predict the efficacy of anti-TNF-α agents? 53
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 53
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 53
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 52
Crohn's disease activity before and after medical therapy evaluated by MaRIA score and others parameters in MR Enterography. 52
TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. 51
Totale 9.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.201
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019211 0 0 0 0 0 0 0 0 0 0 118 93
2019/20201.418 268 106 89 51 90 106 158 72 121 86 173 98
2020/20211.193 58 141 20 116 176 89 133 24 126 75 202 33
2021/20221.744 120 83 37 101 123 57 26 241 86 190 345 335
2022/20233.959 513 511 297 601 238 467 195 343 455 80 161 98
2023/20241.901 105 537 99 153 100 317 186 94 124 134 52 0
Totale 12.463